Julie Lepin joined BeOne as Senior Vice President, Chief Regulatory Affairs Officer in September 2024.
Ms. Lepin has held key positions at global companies including Amgen and Merck, where she served as Vice President, Regulatory Affairs Oncology, as well as at innovative biotechnology startups, including Juno, Sana Biotechnology and Mural Oncology.
Ms. Lepin earned a B.S. in biochemistry and a diploma in ethics and theology from King’s College London and an M.A. in regulatory affairs from Cardiff University.